Trial Profile
Tamoxifen to Treat Barrett's Metaplasia
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tamoxifen (Primary)
- Indications Barrett's oesophagus
- Focus Therapeutic Use
- 14 Jul 2016 Status changed from recruiting to discontinued.
- 05 Apr 2015 Planned number of patients changed from 30 to 12, as reported by ClinicalTrials.gov.
- 08 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.